Popular Articles

Technology To Improve Accuracy Of Ovarian Cancer Diagnosis
Moffitt Cancer Center and Frantz BioMarkers, LLC have signed a license agreement on phospholipid biomarkers of ovarian cancer. Frantz BioMarkers, which has been granted exclusive worldwide rights to Moffitt"s interests in the biomarkers, will pay initiation, developmental milestone and license maintenance fees, and royalties on sales. Moffitt and Frantz BioMarkers will collaborate on ovarian cancer biomarker research, combining use of these licensed markers with lipid markers developed independently by Frantz BioMarkers.
generic viagra online
Why African Americans Are At Greater Risk Of Hypertension And Kidney Disease
Physician-scientists from NewYork-Presbyterian Hospital/Weill Cornell Medical Center believe that a heightened level a certain growth factor in the blood may explain why blacks have a greater prevalence of hypertension and kidney disease compared to whites. Results from a new study are the first to show that an elevated level of a protein, called transforming growth factor b1 (TGF-b1), raises the risk of hypertension and renal disease in humans.
News of the day
How African American Men Decide Whether Or Not To Get Prostate Cancer Screening
UroToday.com - Prostate Cancer Screening among African Americans. Our manuscript that was published in Cancer Nursing, revealed an important topic in how African American men decided whether or not to get a prostate cancer screening. This is particularly important currently due to the controversy of prostate cancer screening.
Health Insurance

ECOSOC's Agenda Should Include Noncommunicable Disease Threat In Developing Countries

"[E]xplicit indicators to measure progress in reducing heart diseases, stroke, diabetes, cancers and chronic respiratory diseases" are missing from the U.N. Economic and Social Council (ECOSOC) agenda as it meets in Geneva this week "to focus on implementing the internationally agreed goals and commitments in regard to public health," and the "omission needs to be urgently addressed if the intent is to have a major impact on reducing poverty by 2015," Ala Alwan, WHO"s assistant director-general for Noncommunicable Diseases and Mental Health; George Alleyne, PAHO"s director emeritus; and Martin Silink, president of the International Diabetes Federation write in an opinion piece in the Hindu. "Infectious diseases still strike at millions in developing countries, but they are rapidly being overtaken by the epidemic of noncommunicable diseases," according to the authors. Alwan, Alleyne and Silink say that "proven policies" can save "[m]illions of lives" through "interventions to reduce tobacco use, unhealthy diets, physical inactivity and harmful use of alcohol, and by strengthening primary care services to respond to the health-care needs of people needing screening, early detection and treatment of noncommunicable diseases." Though there have been "some recent promising initiatives," developing countries face challenges today that are "already greater than at any time since noncommunicable diseases became a problem in industrialised countries," write the authors. The authors conclude that combating noncommunicable diseases "requires strong global and national partnerships," noting that WHO this week is launching a Global Noncommunicable Disease Network, and they call on "[r]ich countries" to support developing countries "through aid and expertise which have led to drastic reductions in deaths from these diseases in their own populations" (Alwan/Alleyne/Silink, 7/8). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):